1.RPM 125(6).indb
TION. Ladislav Slovacek. Birgita Slovackova. Ladislav Jebavy. Zuzana Macingova. Psychosocial, health and demographic characteristics of quality of life among ...
a12v1256 | 
www.scielo.br Facebook LIKES: 89
2.APPLICATION OF BIOHYDROMETALLURGICAL PROCESSES ...
MACINGOVA. 2 ..... LUPTAKOVA, A., MACINGOVA, E., UBALDINI, S., FORNARI, P., ... MACINGOVA, E.: New technologies for heavy metals removal from Acid ...
Ubaldini_Luptakova_2010_NB1 | nbc-journal.fpv.ucm.sk Facebook LIKES: 0
3.METALS RECOVERY FROM ACID MINE DRAINAGE
(luptakal@saske.sk, jencarova@saske.sk, macingova@saske.sk, prascak@ saske.sk). 2Institute of Building and Environmental Engineering, Civil Engineering ...
Luptakova_2010_NB1 | nbc-journal.fpv.ucm.sk Facebook LIKES: 0
4.POSITIVE AND NEGATIVE ASPECTS OF SULPHATE-REDUCING ...
(luptakal@saske.sk), (macingova@saske.sk). 2Technical University of Košice, Civil Engineering Faculty, Institute of Building and. Environmental Engineering ...
Luptakova_2009_NB2 | nbc-journal.fpv.ucm.sk Facebook LIKES: 0
5.Tamoxifen/Norfloxacin interaction leading to QT interval ...
tab Dispos 2002; 30: 869–874. 4. Slovacek L, Ansorgova V, Macingova Z, Haman L, Petera J. Ta- moxifen-induced QT interval prolongation. J Clin Pharm 2008; ...
11206-10 | www.bmj.sk Facebook LIKES: 0
6.Tamoxifen and arrhythmia
Oct 21, 2009 ... Slovacek L, Ansorgova V, Macingova Z, Haman L, Petera J. Tamoxifen-induced QT interval prolongation. J Clin Pharm Ther. 2008;33:453–5. 3.
t285575275h13345 | www.springerlink.com Facebook LIKES: 257
7.ABSTRACTS LIST PRESENTED BY TOPICS (IBBS-14)
Luptakova Alena, Macingova Eva, Jencarova. Jana, Balintova Magdalena ... Macingova Eva, Luptakova Alena, Jencarova. Jana. Alena Luptakova. Poster ...
IBBS14-list | www.ibbs-14.org Facebook LIKES: 0
8.Patients' Satisfaction with Different Modalities of Prostate Cancer ...
Paluska P, Zouhar M, Jansa J, Macingova Z, Jarosova L, Brodak. M, Moravek P and Hartmann I: Dose escalation in prostate radiotherapy up to 82 Gy using ...
3903.full | ar.iiarjournals.org Facebook LIKES: 0
